Ion channels in the immune system as targets for immunosuppression

Current Opinion in Biotechnology

Volumn 8, Issue 6, 1997, Pages 749-756

  Cahalan, Michael D ^a   Chandy, K George ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; ION CHANNEL; POTASSIUM CHANNEL; SODIUM CHANNEL;

CELL VOLUME; DRUG TARGETING; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE;

EID: 0030720015     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(97)80130-9     Document Type: Review

References (98)

1. Crabtree GR, Clipstone NA. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu Rev Biochem. 63:1994;1045-1083.
2. Lewis RS, Cahalan MD. Potassium and calcium channels in lymphocytes. Annu Rev Immunol. 13:1995;623-653.
3. Negulescu PA, Shastri N, Cahalan MD. Intracellular calcium dependence of gene expression in single T lymphocytes. Proc Natl Acad Sci USA. 91:1994;2873-2877.
4. Fanger CM, Hoth M, Crabtree GR, Lewis RS. Characterization of T cell mutants with defects in capacitative calcium entry: genetic evidence for the physiological roles of CRAC channels. J Cell Biol. 131:1995;655-667.
5. 2+ dependence of gene expression.
6. 2+ plateau. Decoding the differential responsiveness of genes to a common second messenger reveals show signaling specificity can be achieved.
7. Khan AA, Steiner JP, Klein MG, Schneider MF, Snyder SH. IP3 receptor: localization to plasma membrane of T cells and cocapping with the T cell receptor. Science. 257:1992;815-818.
8. Khan AA, Soloski MJ, Sharp AH, Schilling G, Sabatini DM, Li SH, Ross CA, Snyder SH. Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor. Science. 273:1996;503-507.
9. 2+ stores. Proc Natl Acad Sci USA. 90:1993;6295-6299.
10. 2+-ATPase inhibitors. J Immunol. 152:1994;5226-5240.
11. Jayaraman T, Ondriasova E, Ondrias K, Harnick DJ, Marks AR. The inositol 1,4,5-trisphosphate receptor is essential for T-cell receptor signaling. Proc Natl Acad Sci USA. 92:1995;6007-6011.
12. 2+ current in human leukemic T cells. Cell Regul. 1:1989;99-112.
13. Zweifach A, Lewis RS. Slow calcium-dependent inactivation of depletion-activated calcium current. Store-dependent and -independent mechanisms. J Biol Chem. 270:1995;14445-14451.
14. Zweifach A, Lewis RS. Rapid inactivation of depletion-activated calcium current ICRAC due to local calcium feedback. J Gen Physiol. 105:1995;209-226.
15. Zweifach A, Lewis RS. Calcium-dependent potentiation of store-operated calcium channels in T lymphocytes. J Gen Physiol. 107:1996;597-610.
16. 2+ current Icrac in T lymphocytes. Br J Pharmacol. 119:1996;647-654.
17. 2+ reserves in activated Jurkat T lymphocytes. Cell Calcium. 19:1996;509-520.
18. Ricci R, Buffelli M, Riviera AP, Cangiano A. An electrophysiological study of calcium entry during normal human T-lymphocyte activation. FEBS Lett. 390:1996;78-80.
19. Serafini AT, Lewis RS, Clipstone NA, Bram RJ, Fanger C, Fiering S, Herzenberg LA, Crabtree GR. Isolation of mutant T lymphocytes with defects in capacitative calcium entry. Immunity. 3:1995;239-250.
20. + channels in intact human T lymphocytes. Non-invasive measurements of membrane currents, membrane potential, and intracellular calcium. J Gen Physiol. 105:1995;765-794.
21. Defarias FP, Stevens SP, Leonard RJ. Stable expression of human Kv1.3 potassium channels resets the resting membrane potential of cultured mammalian cells. Recept Channels. 3:1995;273-281.
22. + channels in human leukemic T cells. J Gen Physiol. 99:1992;1-23.
23. Grissmer S, Nguyen AN, Cahalan MD. Calcium-activated potassium channels in resting and activated human T lymphocytes. J Gen Physiol. 102:1993;601-630.
24. 2+-activated potassium channels in human leukaemic T lymphocytes. J Physiol. 496:1996;627-637.
25. + channels. J Physiol. 503:1997;317-331.
26. Hess S, Oortgiesen M, Cahalan MD. Calcium oscillations in human T and natural killer cells depend upon membrane potential and calcium influx. J Immunol. 150:1993;2620-2633.
27. 2+ signaling. Cell Calcium. 17:1995;287-300.
28. Ca channels.
29. + channels in human T lymphocytes: a role in mitogenesis? Nature. 307:1984;465-468.
30. Matteson DR, Deutsch C. K channels in T lymphocytes: a patch clamp study using monoclonal antibody adhesion. Nature. 307:1984;468-471.
31. Cahalan MD, Chandy KG, DeCoursey TE, Gupta S. A voltage-gated potassium channel in human T lymphocytes. J Physiol. 358:1985;197-237.
32. Chandy KG, DeCoursey TE, Cahalan MD, McLaughlin C, Gupta S. Voltage-gated potassium channels are required for human T lymphocyte activation. J Exp Med. 160:1984;369-385.
33. Knaus HG, Koch RO, Eberhart A, Kaczorowski GJ, Garcia ML, Slaughter RS. [125l]margatoxin, an extraordinarily high affinity ligand for voltage-gated potassium channels in mammalian brain. Biochemistry. 34:1995;13627-13634.
34. + channel revealed by the NMR-derived structures of scorpion toxins. Neuron. 15:1995;1169-1181.
35. + channel antagonists that exhibit immunosuppressive actions. Such agents could be used to prevent graft rejection following transplantation, for the treatment of autoimmune disease, or to reduce inflammation.
36. Pennington MW, Mahnir VM, Krafte DS, Zaydenberg I, Byrnes ME, Khaytin I, Crowley K, Kem WR. Identification of three separate binding sites on SHK toxin, a potent inhibitor of voltage-dependent potassium channels in human T-lymphocytes and rat brain. Biochem Biophys Res Commun. 219:1996;696-701.
37. Rader RK, Kahn LE, Anderson GD, Martin CL, Chinn KS, Gregory SA. T cell activation is regulated by voltage-dependent and calcium-activated potassium channels. J Immunol. 156:1996;1425-1430.
38. + channels in human T lymphocytes. Mol Pharmacol. 48:1995;98-104.
39. + channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol. 45:1994;1227-1234.
40. Michne WF, Guiles JW, Treasurywala AM, Castonguay LA, Weigelt CA, O'connor B, Volberg WA, Grant AM, Chadwick CC, Krafte DS, et al. Novel inhibitors of potassium ion channels on human T lymphocytes. J Med Chem. 38:1995;1877-1883.
41. Nguyen A, Kath JC, Hanson DC, Biggers MS, Canniff PC, Donovan CB, Mather RJ, Bruns MJ, Rauer H, Aiyar J, et al. Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation. Mol Pharmacol. 50:1996;1672-1679.
42. Kath JC, Hanson DC, Chandy KG. T lymphocyte potassium channel blockers. Annu Rep Med Chem. 32:1997;181-190.
43. Helms LM, Felix JP, Bugianesi RM, Garcia ML, Stevens S, Leonard RJ, Knaus HG, Koch R, Wanner SG, Kaczorowski GJ, Slaughter RS. Margatoxin binds to a homomultimer of K V 1.3 channels in Jurkat cells. Comparison with K V 1.3 expressed in CHO cells. Biochemistry. 36:1997;3737-3744.
44. Lin CS, Boltz RC, Blake JT, Nguyen M, Talento A, Fischer PA, Springer MS, Sigal NH, Slaughter RS, Garcia ML, et al. Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation. J Exp Med. 177:1993;637-645.
45. + channels in human and murine T lymphocytes. J Gen Physiol. 93:1989;1061-1074.
46. Price M, Lee SC, Deutsch C. Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes. Proc Natl Acad Sci USA. 86:1989;10171-10175.
47. Chandy KG, Williams CB, Spencer RH, Aguilar BA, Ghanshani S, Tempel BL, Gutman GA. A family of three mouse potassium channel genes with intronless coding regions. Science. 247:1990;973-975.
48. + channel gene. Proc Natl Acad Sci USA. 87:1990;9411-9415.
49. Douglass J, Osborne PB, Cai YC, Wilkinson M, Christie MJ, Adelman JP. Characterization and functional expression of a rat genomic DNA clone encoding a lymphocyte potassium channel. J Immunol. 144:1990;4841-4850.
50. + channels in human T lymphocytes. J Biol Chem. 267:1992;8650-8657.
51. Chandy KG, Gutman GA. Voltage-gated potassium channel genes. North RA. Ligand and Voltage-gated Ion Channels. Handbook of Receptors and Channels. 1995;1-71 CRC Press, Boca Raton.
52. Spencer RH, Sokolov Y, Li H, Takenaka B, Milici AJ, Aiyar J, Nguyen A, Park H, Jap BK, Hall JE, et al. Purification, visualization, and biophysical characterization of Kv1.3 tetramers. J Biol Chem. 272:1997;2389-2395.
53. + channels contain multiple intersubunit association sites. J Biol Chem. 271:1996;18904-18911.
54. + channel gene expression. Biophys J. 68:1995;147-156.
55. Panyi G, Deutsch G. Assembly and suppression of endogenous Kv1.3 channels in human T cells. J Gen Physiol. 107:1996;409-420.
56. Koo GC, Blake JT, Talento A, Nguyen M, Lin S, Sirotina A, Shah K, Mulvany K, Hora D Jr, Cunningham P, et al. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. of special interest J Immunol. 158:1997;5120-5128 A potent peptide antagonist of Kv1.3 margatoxin, administered intravenously, suppressed delayed-type hypersensitivity and allogeneic responses in pigs. The peptide was 40-100-fold more potent than FK506, a clinically used immunosuppressant. The immunosuppression lasted 2-3 weeks after cessation of treatment. No acute side effects were observed during the eight days of therapy, except for mild thymic aplasia. This paper validates the concept that Kv1.3 blockers would be efficacious and safe immunosuppressants.
57. Levy DI, Deutsch C. Recovery from C-type inactivation is modulated by extracellular potassium. Biophys J. 70:1996;798-805.
58. + in recovery from C-type inactivation. Biophys J. 71:1998;3157-3166.
59. + channel occurs by a cooperative mechanism. Biophys J. 69:1995;896-903.
60. + channels: evidence for non-conducting closed and non-conducting inactivated states. J Physiol. 1997;. in press.
61. + channel block by verapamil and related compounds in rat alveolar epithelial cells. J Gen Physiol. 106:1995;745-779.
62. Rauer H, Grissmer S. Evidence for an internal phenylalkylamine action on the voltage-gated potassium channel Kv1.3. Mol Pharmacol. 50:1996;1625-1634.
63. + channels are modulated by 5-HT1c receptor activation and independently by PKC. Am J Physiol. 265:1993;C1571-C1578.
64. Chung I, Schlichter LC. Native Kv1.3 channels are upregulated by protein kinase C. J Membr Biol. 156:1997;73-85.
65. Cai YC, Douglas J. In vivo and in vitro phosphorylation of the T lymphocyte type n (Kv1.3) potassium channel. J Biol Chem. 268:1993;23720-23727.
66. + channel in T lymphocytes upon Fas stimulation. J Biol Chem. 271:1996;20465-20469.
67. Gulbins E, Szabo I, Baltzer K, Lang F. Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases. Proc Natl Acad Sci USA. 94:1997;7661-7666.
68. Holmes TC, Fadool DA, Levitan IB. Tyrosine phosphorylation of the Kv1.3 potassium channel. J Neurosci. 16:1996;1581-1590.
69. Fadool DA, Holmes TC, Berman K, Dagan D, Levitan IB. Tyrosine phosphorylation modulates current amplitude and kinetics of a neuronal voltage-gated potassium channel. J Neurophysiol. 48:1997;1563-1573.
70. Bowlby MR, Fadool DA, Holmes TC, Levitan IB. Modulation of the Kv1.3 potassium channel by receptor tyrosine kinases. J Gen Physiol. 110:1997;. in press.
71. Hanada T, Lin L, Chandy KG, Oh SS, Chishti AH. hDlg: human homologue of the Drosophila discs large tumor suppressor binds to p56lck tyrosine kinase and Shaker type Kv1.3 potassium channel in T lymphocytes. J Biol Chem. 272:1997;26899-26904.
72. Simon M, Conley EC, Shelton PA, Gutman GA, Chandy KG. Transcription of the T-cell potassium channel Kv1.3 is regulated by a GC-rich TATA-less promoter. Cell Physiol Biochem. 7:1997;243-250.
73. Autieri MV, Belkowski SM, Constantinescu CS, Cohen JA, Prystowsky MB. Lymphocyte-specific inducible expression of potassium channel beta subunits. J Neuroimmunol. 1:1997;8-16.
74. + channels in primary human T lymphocytes. J Gen Physiol. 99:1992;771-793.
75. + channels in murine thymocyte development. J Biol Chem. 270:1995;22406-22411.
76. 2+ signaling, and receptor gene expression in antigen-specific mouse T cells. J Immunol. 159:1997;1628-1638.
77. + channel in T cells. J Biol Chem. 267:1992;20971-20979.
78. + channels. SKCa2 and 3 are apamin-sensitive, while SKCa1 is not. Several ESTs for SKCa3, isolated from lymphoid cells, exist in GenBank (GenBank:www.ncbi.nlm.nih.gov).
79. Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, Maylie J. A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci USA. 94:1997;11651-11656.
80. Joiner WJ, Wang L-Y, Tang MD, Kaczmarek LK. hSKA4, a member of a novel subfamily of calcium-activated potassium channels. Proc Natl Acad Sci USA. 94:1997;11013-11018.
81. Le Deist F, Hivroz C, Partiseti M, Thomas C, Buc HA, Oleastro M, Belohradsky B, Choquet D, Fischer A. A primary T-cell immunodeficiency associated with defective transmembrane calcium influx. Blood. 85:1995;1053-1062.
82. 3+ concentrations block the calcium release-activated channel, and impair CD69 and DC25 expression in CD3- or thapsigargin-activated Jurkat cells. Biochemical J. 313:1996;909-913.
83. 2+ influx pathways mediated by swelling or stores depletion in mouse thymocytes. J Gen Physiol. 106:1995;415-444.
84. 2+ channels ICRAC in Jurkat T cells. Biophys J. 71:1996;787-794.
85. Cahalan MD, Lewis RS. Role of potassium and chloride channels in volume regulation by T lymphocytes. Gunn R, Parker J. Cell Physiology of Blood. 1988;282-301 Rockefeller University Press, New York.
86. Lewis S, Ross PE, Cahalan MD. Chloride channels activated by osmotic stress in T lymphocytes. J Gen Physiol. 101:1993;801-826.
87. Ross PE, Garber SS, Cahalan MD. Membrane chloride conductance and capacitance in Jurkat T lymphocytes during osmotic swelling. Biophys J. 66:1994;169-178.
88. Schumacher PA, Sakellaropoulos G, Phipps DJ, Schlichter LC. Small-conductance chloride channels in human peripheral T lymphocytes. J Membr Biol. 145:1995;217-232.
89. Steinert M, Grissmer S. Novel activation stimulus of chloride channels by potassium in human osteoblasts and human leukaemic T lymphocytes. J Physiol. 500:1997;653-660.
90. Cahalan MD, Lewis RS. Regulation of chloride channels in lymphocytes. Guggino W. Current Topics in Membranes. Chloride Channels. 42:1994;103-129 Academic Press, San Diego.
91. Phipps DJ, Branch DR, Schlichter LC. Chloride-channel block inhibits T lymphocyte activation and signalling. Cell Signal. 8:1996;141-149.
92. Baricordi OR, Ferrari D, Melchiorri L, Chiozzi P, Hanau S, Chiari E, Rubini M, Di Virgilio F. An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood. 87:1996;682-690.
93. Chvatchko Y, Valera S, Aubry JP, Renno T, Buell G, Bonnefoy JY. The involvement of an ATP-gated ion channel, P 2X1, in thymocyte apoptosis. Immunity. 3:1996;275-283.
94. Di Virgilio F, Ferrari D, Falzoni S, Chiozzi P, Munerati M, Steinberg TH, Baricordi OR. P2 purinoceptors in the immune system. Ciba Found Symp. 198:1996;290-302.
95. Apasov SG, Koshiba M, Chused TM, Sitkovsky MV. Effects of extracellular ATP and adenosine on different thymocyte subsets: possible role of ATP-gated channels and G protein-coupled purinergic receptor. J Immunol. 158:1997;5095-5105.
96. Jamieson GP, Snook MB, Thurlow PJ, Wiley JS. Extracellular ATP causes of loss of L-selectin from human lymphocytes via occupancy of P2Z purinoceptors. J Cell Physiol. 166:1996;637-642.
97. Koshiba M, Apasov S, Sverdlov V, Chen P, Erb L, Turner JT, Weisman GA, Sitkovsky MV. Transient up-regulation of P2Y2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes. Proc Natl Acad Sci USA. 94:1997;831-836.
98. Ross PE, Ehring GR, Cahalan MD. Dynamics of ATP-induced calcium signaling in single mouse thymocytes. J Cell Biol. 138:1997;987-998.